what is the difference between car-t ... - Advanced Prostate...

Advanced Prostate Cancer

23,805 members29,086 posts

what is the difference between car-t and provenge?

5 Replies

both are similar procedures, maybe even the same.

i assume car-t tries to get t-cells, whereas Provenge tries to get dendrites (Dendrion). not sure if this is significant, or how. both are phagocytes i think. the antigen presented must be different, assuming that both add a presented antigen. ...

Provenge is 3x, and car-t is 1x (i believe). $100k vs $400k but i didnt mean that.

Read more about...
5 Replies
ctarleton profile image
ctarleton

It is my understanding that Provenge (Sipuleucel-T) is an immunostimulant. As described in previous Papers:

"A course of treatment consists of three basic steps:

The patient's white blood cells, primarily dendritic cells, a type of antigen-presenting cells (APCs), are extracted in a leukapheresis procedure.

The blood product is sent to a production facility and incubated with a fusion protein (PA2024) consisting of two parts: The antigen prostatic acid phosphatase (PAP), which is present in 95% of prostate cancer cells and

an immune signaling factor granulocyte-macrophage colony stimulating factor (GM-CSF) that helps the APCs to mature.

The activated blood product (APC8015) is returned from the production facility to the infusion center and reinfused into the patient."

This most recent link goes into considerable detail concerning the CAR-T treatment that was recently approved by the US FDA for a type of childhood leukemia, and how it works:

cancer.gov/about-cancer/tre...

in reply toctarleton

yes, but what are the differences? conceptually.

Provenge comes back in a few days. CAR-T comes back in a few weeks.

khanacademy.org/science/bio...

Beauxman profile image
Beauxman

They are very different. Provenge won't cure you. Car-T might kill you. "The first fatal adverse event due to off-tumor recognition by a CAR occurred in a patient with colorectal cancer treated with high numbers of T cells expressing a third generation CAR targeting ERBB2/HER2 [95]. The patient developed respiratory distress and cardiac arrests shortly after the T cell transfer and died of multisystem organ failure 5 days later." - ncbi.nlm.nih.gov/pmc/articl...

in reply toBeauxman

why?

For clarification, both treatments (I assume) hope to infuse professional antigen presenting cells. What is different about these infused cells, their structure, or whatever is the essential difference.

Not what you're looking for?

You may also like...

Car T vs Provenge treatment

Do any of the wise sages on here know if Car T and provenge are basically the same thing? I have...
joeguy profile image

Early results for City of Hope CAR-T

Dr Dorff presented early data for the first 12 CAR-T trial patients at the American Society of...
Javelin18 profile image

Provenge and The Mayo Clinic

I have had a number of requests for further info. I went to The Mayo Clinic for the Choline 11 Pet...
gusgold profile image

B.A.T and Provenge trial.

After 9mo the Arv-766 started to fail. I will be starting a combination therapy trial through Yale...

Provenge - is it worth it?

"Immunotherapies have so far been disappointing for PC, except for Provenge. But some are doubtful...
monte1111 profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.